ANNOVIS BIO INC. COMMON STOCK
3.2100
06-6月-25 13:30:00
15 分の遅延
株式
+0.1600
+5.25%
本日の幅
3.0311 - 3.4000
ISIN
N/A
ソース
NYSE
-
29 4 2024 07:10:00 提供 Nasdaq GlobeNewswire
-
02 4 2024 04:30:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
20 3 2024 04:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
27 2 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
14 2 2024 04:30:00 提供 Nasdaq GlobeNewswire
-
30 1 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
24 1 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio to Participate in the 139th Yale CEO Summit
11 12 2023 10:00:00 提供 Nasdaq GlobeNewswire
-
05 12 2023 04:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Appoints Andrew Walsh as Vice President Finance
01 12 2023 04:30:00 提供 Nasdaq GlobeNewswire
-
27 11 2023 04:30:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
08 11 2023 14:00:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 05:02:38 提供 Nasdaq GlobeNewswire
-
Annovis Bio Announces First Quarter 2023 Financial Results and Provides Corporate Update
11 5 2023 04:00:01 提供 Nasdaq GlobeNewswire
-
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit
11 3 2021 04:05:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio to Present at the BIO CEO & Investor Digital Conference
16 2 2021 03:45:00 提供 Nasdaq GlobeNewswire